Illumina Aktie

97,76 EUR +0,75 EUR +0,77 %

21:55:49

STU

116,83 USD +2,47 USD +2,16 %

21:59:59

BTT

Illumina jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.15,00 Mrd. EUR

KGV24,68Div. Rendite0,00%

WKN927079

ISINUS4523271090

SymbolILMN

Illumina Aktien News

Sortieren:Datum Meistgelesen

07.05.24PR NewswireIllumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL

03.05.24PR NewswireIllumina To Webcast Upcoming Investor Conference

02.05.24PR NewswireIllumina Reports Financial Results for First Quarter of Fiscal Year 2024

12.04.24PR NewswireIllumina's planned divestment of GRAIL approved by the European Commission

09.04.24PR NewswireIllumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer

04.04.24PR NewswireIllumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024

27.02.24PR NewswireJenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China

15.01.24PR NewswireConcentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world

09.01.24PR NewswireIllumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023

06.01.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN

05.01.24PR NewswireIllumina expands collaboration with Janssen to advance molecular residual disease cancer test

04.01.24PR NewswireIllumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024

04.01.24PR NewswireILLUMINA INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options

04.01.24PR NewswireThe Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk

29.12.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN

26.12.23PR NewswireSHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline

19.12.23PR NewswireIllumina To Webcast Upcoming Investor Conference

18.12.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN

18.12.23PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ: ILMN)

17.12.23PR NewswireIllumina Announces Decision to Divest GRAIL

14.12.23PR NewswireILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit

11.12.23PR NewswireIllumina submits Form 10 to the Securities and Exchange Commission

10.12.23PR NewswireILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options

10.12.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN

06.12.23PR NewswireILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit

05.12.23PR NewswireSHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline

30.11.23PR NewswireILLUMINA INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options

30.11.23PR NewswireROSEN, SKILLED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN

29.11.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN

28.11.23PR NewswireILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit

27.11.23PR NewswireSHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of January 9, 2024

23.11.23PR NewswireROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN

22.11.23PR NewswireILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit

21.11.23PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ: ILMN)

16.11.23PR NewswireSHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc.(ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline

14.11.23PR NewswireIllumina To Webcast Upcoming Investor Conferences

13.11.23PR NewswireIllumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries

01.11.23PR NewswireIllumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors

13.10.23PR NewswireIllumina responds to European Commission's divestiture order

Illumina News

Illumina News: auf dieser Seite finden Sie alle Illumina News und Nachrichten zur Illumina Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Illumina News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Illumina News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.